FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
latest-news-card-1
Human Drugs

FDA Sued Over Drug Compounding Restrictions

FarmaKeio Outsourcing, a drug compounding outfit, files a lawsuit against FDA seeking a court order to permit the compounding of sodium thiosulfate.

latest-news-card-1
Medical Devices

Medtronics Affera Mapping/Abalation Device Approved

FDA approves Medtronics Affera Mapping and Ablation System with Sphere-9 Catheter for treating persistent atrial fibrillation.

Animal Drugs

Animal Drug Regs Amended to Reflect Approvals

Federal Register notice: FDA amends its animal drug regulations to reflect application-related actions for new animal drug-related applications.

latest-news-card-1
Medical Devices

Kinova Recalls Wheelchair Robotic Arm

Kinova recalls (Class 1) its Jaco assistive robotic arm to correct the device due to an increased fire hazard.

latest-news-card-1
Medical Devices

Safety Alert on Hologics BioZorb Markers

FDA issues a safety alert recommending that healthcare providers not use BioZorb Markers and BioZorb LP Markers manufactured by Hologic.

latest-news-card-1
Human Drugs

Iterum Therapeutics Antibiotic OKd for UTIs

FDA approves an Iterum Therapeutics NDA for Orlynvah (sulopenem etzadroxil and probenecid) for treating certain uncomplicated urinary tract infections...

latest-news-card-1
Human Drugs

Orphan Status for Sickle Cell Disease Drug

FDA grants Kind Pharmaceutical an orphan drug designation for AND017 and its use in treating sickle cell disease.

latest-news-card-1
Medical Devices

Smiths Medical Recalls Tracheostomy Products

Smiths Medical recalls specific lots of its BLUSelect, BLUgriggs, and BLUperc products due to a manufacturing defect.

Human Drugs

Support for Biosimilar Product Class Guidances

PhRMA and USP recommend that FDA develop product class-specific guidances rather than product-specific guidances to spur the development of new biosim...

latest-news-card-1
Federal Register

Panel To Discuss 503A Bulk Drug Additions

Federal Register notice: FDA announces a 12/4 Pharmacy Compounding Advisory Committee meeting to discuss various bulk drug substances being considered...